Peptidyl-threonine modification

pathway activity — cross-omics
GO:0018210Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Peptidyl-threonine modification pathway is significantly associated with the RNA expression of multiple genes, with the CCRCC cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are RUVBL1-AS1, LINC01975, and EML1, each associated with the pathway in up to 3 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Peptidyl-threonine modification activity versus RUVBL1-AS1 in CCRCC (Pearson r = 0.14).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
CCRCCRUVBL1-AS1 →-1.123-0.366.006<.00132
CCRCCLINC01975 →-0.420-0.350.004<.00132
CCRCCEML1 →-0.650-0.366.005<.00132
BRCATMED8 →-0.678-0.400<.001.00332
BRCANEK9 →-0.480-0.286<.001.00323
BRCANEDD1 →-0.735-0.472.001.00332
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0018210 vs RUVBL1-AS1 — CCRCC

Per-sample scatter of Peptidyl-threonine modification activity vs RUVBL1-AS1 in CCRCC.

Explore this scatter interactively →

Exploration